- $17.12m
- $222.30m
- $266.13m
Annual income statement for System1, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 688 | 665 | 402 | 344 | 266 |
| Cost of Revenue | |||||
| Gross Profit | 167 | 185 | 153 | 152 | 100 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 638 | 1,159 | 490 | 412 | 328 |
| Operating Profit | 50.8 | -494 | -88 | -68.5 | -62 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 34 | -531 | -132 | -97.7 | -84.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 33 | -421 | -111 | -97.3 | -81.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 33 | -367 | -227 | -74.7 | -65.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 33 | -367 | -227 | -74.7 | -65.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.88 | -8.88 | -9.23 | -12.6 | -8.32 |
| Dividends per Share |